Navigation Links
BioConvergence® Presents Case Study on Temperature Controlled Pharmaceutical Products
Date:10/19/2013

Bloomington, Indiana (PRWEB) October 18, 2013

BioConvergence team members Désirée Valentine and Travis Hudson presented their newest case study (including outcomes of yielding a 99.7 percent excursion-free shipping rate) at the 11th Annual Cold Chain & Temperature Management Global Forum in Chicago, IL earlier this month.

The conference, led by IQPC, focused on shipping regulations, strategies, and trends within the life sciences industry, with special emphasis on maintaining product integrity through temperature management.

“There is plenty of evidence that suggests that a product’s temperature (and the associated fluctuations) can have profound impacts on a product’s stability, and therefore, its therapeutic effectiveness,” relates Valentine, Senior Supply Chain Manager at BioConvergence. “Because of this, BioConvergence is committed to keeping our clients’ products within appropriate temperature conditions while at our facility and throughout transit. This year, our team has implemented key changes that have resulted in improved metrics and additional value to clients. In presenting this data at IQPC, we hope that others will utilize this case study to realize similar results and promote improvements throughout the pharmaceutical supply chain.”

These improvements, as were discussed in Valentine and Hudson’s presentation, are as follows:

  •     Yielded a 99.7 percent excursion-free rate
  •     Decreased Average Days in Transit by over 1 day per shipment
  •     Reduced Days in Transit (50% reduction in “Delivery Past Qualification” time)
  •     Improved coordination, both internally and externally
  •     Established processes for continual improvement moving forward

When asked how BioConvergence achieved these results, Hudson, Associate Process Engineer at BioConvergence, responded, “We began by having a clear picture of the results we wanted to see: improvements to key performance indicators and partnerships, as well as reductions to excursion rates. Next, we began an in-depth analysis of our existing processes and flagged five specific root causes that were interfering with outcomes. After strategically addressing each of these items, we began to see improvements in our metrics. This process has become the standard at BioC in promoting continual improvements.”

In addition to presenting this case study, Valentine and Hudson also led a roundtable discussion during the conference entitled, “How to Create Value through Designing and Implementing a Shipping Lane Qualification for High Value Pharmaceutical Products.”

To learn more about the framework BioConvergence developed, download the full case study at http://www.bioc.us/iqpc.

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, BioC has over 50 employees with more than four centuries’ worth of combined experience in the pharmaceutical industry. BioC’s unique E-Transparency® System provides transparency and flexibility to its clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11245946.htm.


'/>"/>
Source: PRWeb
Copyright2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
2. CEO of BioConvergence® Receives Women Excel Bloomington Award for Outstanding Leadership and Service
3. BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment
4. BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
5. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
6. Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
7. FarHawk Marketing Services Represents IonBench™ and MS Noise™ at the Greater Boston Mass Spectrometry Discussion Group Corporate Night October 3rd
8. San Francisco Business Times Presents: Richmond! Your Home Front for Business
9. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
10. Bayer CropScience Presents on Bee Health and Stewardship at International Pollinator Conference
11. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , Mar. 24, 2017 Research and ... Cell (hESC) Research - Global Strategic Business Report" report to ... ... (hESC) Research in US$ Million. Annual estimates and forecasts are provided ... derived from primary and secondary research. The report ...
(Date:3/24/2017)... -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with ... today announced participation at the following conferences: ... Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at the ... York, NY . Agenus will participate in three ... Robert B. Stein , M.D., Ph.D., President, R&D ...
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... recently selected by the Connecticut Technology Council (CTC) as a 2017 Women of ... thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished ...
Breaking Biology Technology:
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: AWRE), ... that Richard P. Moberg has resigned, effective ... and Chief Financial Officer and Treasurer of Aware citing ... serve as a member of the Board of Directors ... Aware,s co-Chief Executive Officer and co-President, General Counsel has ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):